 Up to 95 of individuals with Multiple Sclerosis report experiencing cognitive fatigue, characterized by a lack of energy, feelings of exhaustion, an the perception that one is unable to partake in daily activities. The goal of this project is to test whether methylphenidate MP, a well-known psychostimulant, can effective treat fatigue experienced by individuals with MS. 